Sign In
Buy PMCB
$0.751
-0.0489 (-6.11%)
At Close: Jun 02, 2026
PMCB Stock: 2 Big Reasons PharmaCyte Biotech Is Soaring 70% Today
03:52pm, Friday, 13'th Aug 2021
Today, two key catalysts are taking PMCB stock higher, as investors seem to like the positioning of biotech PharmaCyte. The post PMCB Stock: 2 Big Reasons PharmaCyte Biotech Is Soaring 70% Today appea
PharmaCyte Biotech Shares Increase Over 94% Intraday: Why It Happened
03:33pm, Friday, 13'th Aug 2021
The shares of PharmaCyte Biotech, Inc. (NASDAQ: PMCB) increased by over 94% during intraday trading. This is why it happened.
PharmaCyte Biotech Announces Uplist Date to NASDAQ and Pricing of $15 Million Public Offering
05:37pm, Monday, 09'th Aug 2021
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $NASDAQ #NASDAQ--PharmaCyte Biotech announces uplist date to NASDAQ and pricing of $15 million public offering.
